Klox Technologies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Klox Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11168
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Klox Technologies Inc (Klox Technologies) is a biomedical technology company that researches, develops and commercializes fluorescence biomodulation (FB) technology products for the treatment of skin and soft tissue disorders. The company develops FB systems to address conditions in the therapeutic areas of dermatology, wound care, animal health, and oral health. Its product pipeline includes Kleresca, for treatment of acne vulgaris and skin care; LumiHeal, for treating chronic wounds, perio-1, for treating periodontitis; and phovia, for the treatment of wounds in animals. It caters to biotechnology, pharmaceutical and medical device industries. The company has operations in Canada, Denmark, Ireland, the US and Italy. Klox Technologies is headquartered in Laval, Quebec, Canada.

Klox Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Klox Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Klox Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 9
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Leo Pharma Enters into Licensing Agreement with Klox Technologies 11
Klox Technologies Enters Into Licensing Agreement With Sandoz Canada 12
Klox Technologies and LEO Pharma to Form Joint Venture 13
Licensing Agreements 14
Colgate-Palmolive Enters into Licensing Agreement with Klox Technologies 14
Equity Offering 15
Klox Technologies Withdraws IPO 15
Klox Technologies Inc – Key Competitors 16
Klox Technologies Inc – Key Employees 17
Klox Technologies Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Klox Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Klox Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Klox Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Klox Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 9
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Leo Pharma Enters into Licensing Agreement with Klox Technologies 11
Klox Technologies Enters Into Licensing Agreement With Sandoz Canada 12
Klox Technologies and LEO Pharma to Form Joint Venture 13
Colgate-Palmolive Enters into Licensing Agreement with Klox Technologies 14
Klox Technologies Withdraws IPO 15
Klox Technologies Inc, Key Competitors 16
Klox Technologies Inc, Key Employees 17
Klox Technologies Inc, Other Locations 18
Klox Technologies Inc, Subsidiaries 18

List of Figures
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Klox Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Klox Technologies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Taiwan Sugar Corp:企業の戦略的SWOT分析
    Taiwan Sugar Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • RP Management LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary RP Management LLC (RP Management) is a life sciences financing company that offers biopharmaceutical products. The company’s products include thalomid, myozyme, lexiscan, rituxan, atripla, lyrica, prezista, letairis, januvia, onglyza, neupogen, rotateq, cubicin, savella, and others. It also …
  • Guangzhou Institute of Biomedicine and Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Guangzhou Institute of Biomedicine and Health (GIBH) is a research institute that develops protocols for disease control and prevention. The institute conducts research in the areas of stem cell and regenerative medicine, chemical biology, immunology and infectious diseases, public health, a …
  • Marshall Aerospace and Defence Group:企業の戦略・SWOT・財務情報
    Marshall Aerospace and Defence Group - Strategy, SWOT and Corporate Finance Report Summary Marshall Aerospace and Defence Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • GN Store Nord AS (GN):企業の財務・戦略的SWOT分析
    GN Store Nord AS (GN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • GenMark Diagnostics Inc (GNMK):企業の財務・戦略的SWOT分析
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test …
  • ICU Medical Inc (ICUI):医療機器:M&Aディール及び事業提携情報
    Summary ICU Medical Inc (ICU Medical) is a medical device company which develops, manufactures, distributes and sells devices used for infusion therapy, cancer diagnosis and treatment and critical care applications. The company’s major products include needle free vascular access devices, closed sys …
  • Landeskreditbank Baden-Wuerttemberg-Foerderbank:企業の戦略・SWOT・財務分析
    Landeskreditbank Baden-Wuerttemberg-Foerderbank - Strategy, SWOT and Corporate Finance Report Summary Landeskreditbank Baden-Wuerttemberg-Foerderbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Libbs Farmaceutica Ltda:製薬・医療:M&Aディール及び事業提携情報
    Summary Libbs Farmaceutica Ltda (Libbs Farmaceutica) is a pharmaceutical company which manufactures and supply medications for human healthcare. The company offers monoclonal antibodies in various specialties which include cardiovascular, gynecology, oncology, dermatology, respiratory, and central n …
  • Tesson Holdings limited:戦略・SWOT・企業財務分析
    Tesson Holdings limited - Strategy, SWOT and Corporate Finance Report Summary Tesson Holdings limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bank of India:企業のM&A・事業提携・投資動向
    Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Trimedyne Inc:企業の戦略的SWOT分析
    Trimedyne Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Coslight Technology International Group Ltd (1043):企業の財務・戦略的SWOT分析
    Coslight Technology International Group Ltd (1043) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • KPS AG (KSC):企業の財務・戦略的SWOT分析
    Summary Kps AG (Kps) is a technology company that offers e-commerce and digital marketing services. The company offers consulting services in the areas of business transformation and process optimization. It offers e-business, wholesale, retail, manufacturing, supply chain management, logistics, ser …
  • Concho Resources Inc.:企業の戦略・SWOT・財務分析
    Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sebia SA:医療機器:M&Aディール及び事業提携情報
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers. The company's electrophoresis program offers automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It …
  • DPT Laboratories Ltd:企業の戦略的SWOT分析
    DPT Laboratories Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Beijing Beilu Pharmaceutical Co Ltd (300016):製薬・医療:M&Aディール及び事業提携情報
    Summary Beijing Beilu Pharmaceutical Co Ltd (Beijing BeiLu) is a manufacturer of traditional Chinese medicine preparation and psychiatric products. The company provides product portfolio such as contrast media products, anti anxiety medicines and oral antihyperglycemic agents, among others. Its cont …
  • New York Power Authority:発電所・企業SWOT分析
    New York Power Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • North China Pharmaceutical Co Ltd (600812):製薬・医療:M&Aディール及び事業提携情報
    Summary North China Pharmaceutical Co Ltd (NCPC), a subsidiary of North China Pharmaceutical Group Corp is a pharmaceutical company that develops, produces and sells novel drugs and pharmaceutical related products. The company offers preparation products, nutrition, pharmaceutical raw materials and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆